Skip to main content

Advertisement

SpringerLink
Log in

Living Donor Versus Deceased Donor Liver Transplantation for HCC

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Liver transplantation is the definitive treatment modality of the patients having an end-stage liver disease with hepatocellular carcinoma.

Discussion

The number of living donor liver transplantations has been increased because of the deceased donor organ shortage, especially in Asian countries.

Conclusion

Reports of different clinics about the postoperative course and tumor recurrence rates comparing living donor versus deceased donor liver transplantations, besides patient selection criteria, are reviewed along with our clinic’s experiences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

Not applicable.

Abbreviations

HCC:

Hepatocellular carcinoma

LDLT:

Living donor liver transplantation

DDLT:

Deceased donor liver transplantation

References

  1. World cancer report. http://publications.iarc.fr/Non-Series- Publications/World-Cancer-Reports/World-Cancer-Report-2014.

  2. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–9.

    Article  CAS  PubMed  Google Scholar 

  3. Akamatsu N, Sugawara Y, Kokudo N. Living donor liver transplantation for patients with hepatocellular carcinoma. Liver Cancer. 2014;3:108–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33(6):1394–403.

    Article  CAS  PubMed  Google Scholar 

  5. Llovet JM, Pavel M, Rimola J, Diaz MA, Colmenero J, Saavedra-Perez D, et al. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan criteria (Barcelona clinic liver cancer extended criteria). Liver Transplant. 2018;24:369–79.

    Article  Google Scholar 

  6. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35–43.

    Article  PubMed  Google Scholar 

  7. Sapisochin G, Goldaracena N, Laurence JM, Dib M, Barbas A, Ghanekar A, et al. The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: a prospective validation study. Hepatology. 2016;64(6):2077–88.

    Article  PubMed  Google Scholar 

  8. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation. 2008;85(12):1726–32.

    Article  CAS  PubMed  Google Scholar 

  9. Ince V, Akbulut S, Otan E, Ersan V, Karakas S, Sahin TT, et al. Liver transplantation for hepatocellular carcinoma: Malatya experience and proposals for expanded criteria. Journal of Gastrointestinal Cancer. 2020;51:998–1005. https://doi.org/10.1007/s12029-020-00424-w.

    Article  CAS  PubMed  Google Scholar 

  10. Gondolesi GE, Roayaie S, Muñoz L, Kim-Schluger L, Schiano T, Fishbein TM, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg. 2004;239:142–9.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kulik L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology. 2004;127:S277–82.

    Article  PubMed  Google Scholar 

  12. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–40.

    Article  CAS  PubMed  Google Scholar 

  13. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002;8:873–83.

    Article  PubMed  Google Scholar 

  14. Cheng SJ, Pratt DS, Freeman RB Jr, et al. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation. 2001;72:861–8.

    Article  CAS  PubMed  Google Scholar 

  15. Todo S, Furukawa H. Japanese study group on organ transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan Ann Surg. 2004;240:451.

    PubMed  Google Scholar 

  16. Di Sandro S, Slim AO, Giacomoni A, et al. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplant Proc. 2009;41:1283–5.

    Article  PubMed  Google Scholar 

  17. Liang W, Wu L, Ling X, Schroder PM, Ju W, Wang D, et al. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl. 2012;18:1226–36.

    Article  PubMed  Google Scholar 

  18. Yang ZF, Poon RT, Luo Y, Cheung CK, Ho DW, Lo CM, et al. Up-regulation of vascular endothelial growth factor (VEGF) in small-for- size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway. J Immunol. 2004;173:2507–15.

    Article  CAS  PubMed  Google Scholar 

  19. Man K, Fan ST, Lo CM, Liu CL, Fung PCW, Liang TB, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg. 2003;237:256–64.

    PubMed  PubMed Central  Google Scholar 

  20. Shi JH, Huitfeldt HS, Suo ZH, Line PD. Growth of hepatocellular carcinoma in the regenerating liver. Liver Transpl. 2011;17:866–74.

    Article  PubMed  Google Scholar 

  21. Emova EA, Glanemann M, Liu L, et al. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines. Eur Surg Res. 2004;36:300–7.

    Google Scholar 

  22. Fisher RA, Kulik LM, Freise CE, Lok ASF, Shearon TH, Brown RS, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant. 2007;7:1601–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Nobuhisa A, Noruhiro K. Liver transplantation for hepatocellular carcinoma from living donor vs. deceased donor. HepatoBiliary Surg Nutr. 2016;5(5):422–8.

    Article  Google Scholar 

  24. Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, et al. Intention-to- treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology. 2011;53:1570–9.

    Article  PubMed  Google Scholar 

  25. Chao SD, Roberts JP, Farr M, Yao FY. Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma. Am J Transplant. 2007;7:1594–600.

    Article  CAS  PubMed  Google Scholar 

  26. Isik B, Ince V, Karabulut K, Kayaalp C, Yilmaz S. Living donor liver transplantation for hepatocellular carcinoma. Transplant Proc. 2012;44(6):713–6.

    Article  Google Scholar 

  27. Kayaalp C, Ince V, Ersan V, Karakas S, Kahraman AS, Yilmaz S. Liver transplantation for hepatocellular carcinoma at Inonu University. J Gastrointest Cancer. 2017;48(3):268–71.

    Article  PubMed  Google Scholar 

  28. Ince V, Carr BI, Bag HG, Koc C, Usta S, Ersan V, et al. Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation. Int J Biol Markers. 2020;35(2):91–5. https://doi.org/10.1177/1724600820921869.

    Article  CAS  PubMed  Google Scholar 

  29. Li C, Wen TF, Yan LN, et al. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int. 2010;9:366–9.

    PubMed  Google Scholar 

  30. Grant RC, Sandhu L, Dixon PR, Greig PD, Grant DR, McGilvray ID. Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transpl. 2013;27:140–7.

    Article  Google Scholar 

  31. Yau T, Tang VY, Yao TJ, et al. Development of Hong Kong liver cancer staging system with treatment strati cation for patients with hepatocellular carcinoma. Gastroenterology 2014;146:1691–700.e3.

  32. Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut. 2016;65:1035–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Liver Transplantation Institute, İnönü University Faculty of Medicine, Elazığ yolu 10.km, 44280, Malatya, Turkey

    Sait Murat Doğan & Koray Kutlutürk

Authors
  1. Sait Murat Doğan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koray Kutlutürk
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed equally to the manuscript.

Corresponding author

Correspondence to Sait Murat Doğan.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Code Availability

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Doğan, S.M., Kutlutürk, K. Living Donor Versus Deceased Donor Liver Transplantation for HCC. J Gastrointest Canc 51, 1104–1106 (2020). https://doi.org/10.1007/s12029-020-00481-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-020-00481-1

Keywords

Search

Navigation